Staar Surgical
STAA
Staar Surgical (STAA) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jul 3, 2026
- EPS actual
- $0.16
- EPS estimate
- $0.22
- EPS surprise
- −27.73%
- Revenue surprise
- +3.24%
- Revenue
- $93.5M
- Revenue estimate
- $90.6M
- Reported
- Aug 12, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $0.22 | $0.16 | −27.73% | $93.5M | SEC |
| Q1 2026 | May 13, 2026 | $0.03 | $0.41 | +1369.53% | $93.5M | SEC |
| Q4 2025 | Mar 3, 2026 | $0.18 | −$0.20 | −211.11% | $57.8M | SEC |
| Q2 2025 | Aug 6, 2025 | −$0.57 | −$0.34 | +40.17% | $44.3M | SEC |
| Q1 2025 | May 7, 2025 | −$0.60 | −$0.52 | +14.14% | $42.6M | SEC |
| Q4 2024 | Feb 11, 2025 | −$0.03 | −$0.51 | −1774.09% | $49.0M | SEC |
| Q3 2024 | Oct 30, 2024 | $0.18 | $0.26 | +44.52% | $88.6M | SEC |
| Q2 2024 | Aug 7, 2024 | $0.24 | $0.39 | +63.25% | $99.0M | SEC |
| Q1 2024 | May 7, 2024 | $0.06 | $0.11 | +74.55% | $77.4M | SEC |
| Q4 2023 | Feb 26, 2024 | $0.18 | $0.13 | −27.29% | $76.3M | SEC |
| Q3 2023 | Nov 1, 2023 | $0.18 | $0.30 | +69.20% | $80.3M | SEC |
| Q2 2023 | Aug 2, 2023 | $0.29 | $0.40 | +39.91% | $92.3M | SEC |
| Q1 2023 | May 3, 2023 | $0.07 | $0.18 | +144.23% | $73.5M | SEC |
| Q4 2022 | Feb 21, 2023 | $0.13 | $0.14 | +3.86% | $64.0M | SEC |
| Q3 2022 | Nov 2, 2022 | $0.20 | $0.37 | +85.00% | $76.0M | SEC |
| Q2 2022 | Aug 10, 2022 | $0.23 | $0.42 | +80.33% | $81.1M | SEC |
| Q1 2022 | May 4, 2022 | $0.15 | $0.29 | +93.33% | $63.2M | SEC |
| Q4 2021 | Feb 23, 2022 | $0.17 | $0.19 | +11.57% | $59.0M | SEC |
| Q3 2021 | Nov 3, 2021 | $0.17 | $0.21 | +25.97% | $58.4M | SEC |
| Q2 2021 | Aug 4, 2021 | $0.08 | $0.27 | +231.70% | $62.4M | SEC |
Quarterly revenue
Frequently asked questions
When did Staar Surgical (STAA) last report earnings?
Staar Surgical last reported on Aug 12, 2026, covering fiscal Q2 2026.
Did STAA beat earnings estimates?
No. Staar Surgical reported EPS of $0.16 for Q2 2026 against a $0.22 estimate — a 27.73% miss.
How much revenue did STAA report last quarter?
Staar Surgical reported $93.5M in revenue for Q2 2026, against a consensus estimate of $90.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.